MedTrace Logo

Vaginal Uphold Hysteropexy and Laparoscopic Sacral Hysteropexy for the Treatment of Uterovaginal Pelvic Organ Prolapse

NCT01377142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2016-06-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate surgical success or failure one year after surgery for pelvic organ prolapse.

Conditions

  • Pelvic Organ Prolapse

Interventions

DEVICE

Laparoscopic sacral hysteropexy

Laparoscopic sacral hysteropexy is performed laparoscopically with or without robotic assistance

DEVICE

Vaginal mesh hysteropexy

Uphold device used which includes sacrospinous ligament fixation

Sponsors & Collaborators

  • The Christ Hospital

    collaborator OTHER

  • Medstar Health Research Institute

    collaborator OTHER

  • Providence Healthcare

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • Women and Infants Hospital of Rhode Island

    collaborator OTHER

  • Greater Baltimore Medical Center

    collaborator OTHER

  • University of North Carolina

    collaborator OTHER

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Robert E Gutman, MD · Medstar Health Research Institute

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01377142 on ClinicalTrials.gov